TABLE 2—
Newly Identified HIV-positive Tests |
||||
Characteristica | Total, No. | No. (%) | OR (95% CI) | AORb (95% CI) |
Totalc | 105 871 | 755 (0.7) | ||
Gender | ||||
Male | 80 101 | 463 (0.6) | 1.00 (Ref) | 1.00 (Ref) |
Female | 25 077 | 280 (1.1) | 1.94 (1.67, 2.26) | 2.30 (1.94, 2.72) |
Age group, y | ||||
13–19 | 11 443 | 21 (0.2) | 0.38 (0.23, 0.59) | 0.36 (0.23, 0.57) |
20–29 | 40 948 | 199 (0.5) | 1.00 (Ref) | 1.00 (Ref) |
30–39 | 25 702 | 232 (0.9) | 1.87 (1.54, 2.27) | 1.93 (1.59, 2.36) |
40–49 | 21 305 | 235 (1.1) | 2.28 (1.88, 2.77) | 2.20 (1.80, 2.68) |
50–64 | 6473 | 68 (1.0) | 2.17 (1.62, 2.88) | 2.02 (1.52, 2.69) |
Race/ethnicity | ||||
White | 32 801 | 160 (0.5) | 1.00 (Ref) | 1.00 (Ref) |
Black | 50 167 | 493 (1.0) | 2.02 (1.69, 2.44) | 2.42 (1.99, 2.95) |
Hispanic | 19 284 | 93 (0.5) | 0.99 (0.76, 1.29) | 1.32 (1.00, 1.73) |
Asian/Pacific Islander | 716 | 0 (0.0) | 0.20 (0.00, 1.07) | NA |
American Indian/Alaska Native | 635 | 4 (0.6) | 1.29 (0.35, 3.39) | 1.59 (0.58, 4.35) |
Other | 1457 | 4 (0.3) | 0.56 (0.15, 1.47) | 1.16 (0.42, 3.15) |
Region | ||||
Northeast | 30 731 | 118 (0.4) | 1.00 (Ref) | 1.00 (Ref) |
Midwest | 2398 | 5 (0.2) | 0.54 (0.17, 1.30) | 0.52 (0.21, 1.28) |
South | 60 324 | 576 (1.0) | 2.50 (2.05, 3.08) | 2.20 (1.76, 2.76) |
West | 12 418 | 56 (0.5) | 1.18 (0.84, 1.63) | 1.10 (0.78, 1.55) |
Risk category | ||||
MSM/IDU | 668 | 16 (2.4) | 3.62 (2.01, 6.12) | 5.44 (3.20, 9.25) |
MSM | 2284 | 83 (3.6) | 5.57 (4.20, 7.34) | 8.14 (6.15, 10.76) |
IDU | 13 627 | 96 (0.7) | 1.05 (0.80, 1.36) | 1.36 (1.04, 1.78) |
High-risk heterosexual contactd | 47 380 | 276 (0.6) | 0.86 (0.71, 1.06) | 0.96 (0.78, 1.18) |
Low-risk heterosexual contacte | 23 036 | 155 (0.7) | 1.00 (Ref) | 1.00 (Ref) |
No acknowledged risk | 12 025 | 68 (0.6) | 0.84 (0.62, 1.12) | 0.73 (0.54, 0.97) |
Otherf | 2699 | 37 (1.4) | 2.05 (1.39, 2.96) | 1.36 (0.94, 1.99) |
Test history | ||||
Previously tested | 75 445 | 502 (0.7) | 1.00 (Ref) | 1.00 (Ref) |
First-time tested | 30 426 | 253 (0.8) | 1.25 (1.07, 1.46) | 2.06 (1.75, 2.42) |
Note. AOR = adjusted odds ratio; CI = confidence interval; IDU = injection drug user; MSM = men who have sex with men; NA = not applicable; OR = odds ratio. Data from the following 16 health departments were included: CA (excluding San Francisco and Los Angeles), DE, DC, FL, GA, LA, MA, MI, NY (excluding New York City), OH, OR, PA (excluding Philadelphia), TX (excluding Houston), VA, San Francisco, and Los Angeles.
The number of records for each variable does not sum to the total number of records because of missing data. The number (percentage) of missing values for the selected variables were as follows: gender, 700 (0.7%); race/ethnicity, 812 (0.8%); and risk category, 4160 (3.9%).
The adjusted regression analysis included test history, gender, age group, race/ethnicity, region, and risk category.
Excludes 251 records with a history of an HIV-positive test.
Person reporting heterosexual contact who also reported any of the following: sex with partner at risk, a diagnosis of a sexually transmitted disease, exchange of sex for drugs or money, noninjection drug use during sex, or a victim of sexual assault.
Person reporting heterosexual contact and no other risk factor.
Person reporting other risk factors (i.e., perinatal exposure, hemophilia, receipt of blood transfusion, or health care exposure).